Skip to main content

Oracea FDA Approval History

FDA Approved: Yes (First approved May 26, 2006)
Brand name: Oracea
Generic name: doxycycline
Dosage form: Capsules
Company: CollaGenex Pharmaceuticals, Inc.
Treatment for: Rosacea

Oracea is a once-a-day capsule formulation of doxycycline, consisting a combination of immediate and delayed release beads. Oracea is indicated for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients.

Development timeline for Oracea

May 26, 2006Approval Oracea CollaGenex Pharmaceuticals, Inc. - Treatment for Rosacea
Oct  3, 2005CollaGenex Pharmaceuticals' New Drug Application for Oracea Accepted for Review by FDA; Target PDUFA Date is May 30, 2006
Aug  1, 2005CollaGenex Pharmaceuticals Files New Drug Application for Oracea

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.